Search for other papers by Weiwei Liang in
Google Scholar
PubMed
Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China
Search for other papers by Yilin Zhang in
Google Scholar
PubMed
Search for other papers by Yan Guo in
Google Scholar
PubMed
Search for other papers by Pengyuan Zhang in
Google Scholar
PubMed
Search for other papers by Jiewen Jin in
Google Scholar
PubMed
Search for other papers by Hongyu Guan in
Google Scholar
PubMed
Search for other papers by Yanbing Li in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common cancer in the endocrine system around the globe, being classified into three main histological subtypes: differentiated (papillary and follicular thyroid cancer), undifferentiated (poorly
Search for other papers by Eugenie S Lim in
Google Scholar
PubMed
Search for other papers by Shanty G Shah in
Google Scholar
PubMed
Search for other papers by Mona Waterhouse in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by Scott Akker in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by William Drake in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by Nick Plowman in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by Daniel M Berney in
Google Scholar
PubMed
Search for other papers by Polly Richards in
Google Scholar
PubMed
Search for other papers by Ashok Adams in
Google Scholar
PubMed
Search for other papers by Ewa Nowosinska in
Google Scholar
PubMed
Search for other papers by Carmel Brennan in
Google Scholar
PubMed
Barts and the London School of Medicine and Dentistry, QMUL, London, UK
Search for other papers by Maralyn Druce in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer (DTC) is the most frequently occurring endocrine cancer and its incidence has been increasing steadily in men and women over the last few decades ( 1 , 2 , 3 ). DTC includes papillary thyroid cancer
Search for other papers by Alexander Heinzel in
Google Scholar
PubMed
Search for other papers by Dirk Müller in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
Emma Children’s Hospital, Amsterdam UMC, Department of Pediatrics, Amsterdam, The Netherlands
Search for other papers by Sarah C Clement in
Google Scholar
PubMed
Search for other papers by Arthur B Schneider in
Google Scholar
PubMed
University Hospital Würzburg, Department of Nuclear Medicine, Würzburg, Germany
Search for other papers by Frederik A Verburg in
Google Scholar
PubMed
Introduction Childhood cancer survivors (CCS) who received radiation therapy to the cervical region (cranial/ cranio-spinal or chest) are at increased risk of developing differentiated thyroid cancer (DTC) among other malignancies. Long
Search for other papers by C Chiapponi in
Google Scholar
PubMed
Search for other papers by H Alakus in
Google Scholar
PubMed
Search for other papers by M Faust in
Google Scholar
PubMed
Search for other papers by A M Schultheis in
Google Scholar
PubMed
Search for other papers by J Rosenbrock in
Google Scholar
PubMed
Search for other papers by M Schmidt in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer (DTC) is often diagnosed postoperatively after resection of sonographic and/or cytological suspicious thyroid nodules. Since its prognosis is excellent in most cases, the main goals of surgery are
Search for other papers by Joana Simões-Pereira in
Google Scholar
PubMed
Search for other papers by Daniel Macedo in
Google Scholar
PubMed
Search for other papers by Maria João Bugalho in
Google Scholar
PubMed
Introduction Thyroid cancer usually has a favorable prognosis with a reported 10-year survival for differentiated and medullary thyroid carcinoma of approximately 80–95% ( 1 ) and 68–85% ( 2 , 3 ), respectively. Distant metastases occur in a
Search for other papers by Nassim Ghaffari-Tabrizi-Wizsy in
Google Scholar
PubMed
Search for other papers by Christina Angelika Passegger in
Google Scholar
PubMed
Search for other papers by Laura Nebel in
Google Scholar
PubMed
Search for other papers by Fabian Krismer in
Google Scholar
PubMed
Search for other papers by Gudrun Herzer-Schneidhofer in
Google Scholar
PubMed
Search for other papers by Gert Schwach in
Google Scholar
PubMed
Search for other papers by Roswitha Pfragner in
Google Scholar
PubMed
Introduction Medullary thyroid cancer (MTC) is a rare thyroid tumour arising from neural-crest-derived parafollicular thyroid C cells, accounting for about 5–8% of all thyroid cancers and may occur sporadic (70–80% of cases) or hereditary (20
Search for other papers by Yuting Shao in
Google Scholar
PubMed
Search for other papers by Xiaole Hu in
Google Scholar
PubMed
Search for other papers by Yuxi Wang in
Google Scholar
PubMed
Search for other papers by Yi Shao in
Google Scholar
PubMed
Search for other papers by Luchuan Li in
Google Scholar
PubMed
Search for other papers by Qingdong Zeng in
Google Scholar
PubMed
Search for other papers by Hong Lai in
Google Scholar
PubMed
Search for other papers by Lei Sheng in
Google Scholar
PubMed
Introduction The incidence of thyroid cancer (TC) has increased rapidly and has ranked the seventh in cancer incidence among female in the United States in 2023 ( 1 ). In China, thyroid cancer is the fourth most common malignancy in female
Grupo de Citogenética, Filogenia y Evolución de Poblaciones, Facultad de Ciencias y Facultad de Ciencias de la Salud, Universidad del Tolima, Ibagué, Tolima, Colombia
Facultad de Ciencias para la Salud, Universidad de Caldas, Manizales, Caldas, Colombia
Search for other papers by Ana P Estrada-Flórez in
Google Scholar
PubMed
Search for other papers by Mabel E Bohórquez in
Google Scholar
PubMed
Hospital Pablo Tobón Uribe, Medellín, Antioquia, Colombia
Search for other papers by Alejandro Vélez in
Google Scholar
PubMed
Search for other papers by Carlos S Duque in
Google Scholar
PubMed
Search for other papers by Jorge H Donado in
Google Scholar
PubMed
Search for other papers by Gilbert Mateus in
Google Scholar
PubMed
Search for other papers by Cesar Panqueba-Tarazona in
Google Scholar
PubMed
Search for other papers by Guadalupe Polanco-Echeverry in
Google Scholar
PubMed
Search for other papers by Ruta Sahasrabudhe in
Google Scholar
PubMed
Search for other papers by Magdalena Echeverry in
Google Scholar
PubMed
Dinamica IPS, Medellín, Antioquia, Colombia
University of California Davis Comprehensive Cancer Center, Sacramento, California, USA
Fundación de Genética y Genómica, Medellín, Antioquia, Colombia
Search for other papers by Luis G Carvajal-Carmona in
Google Scholar
PubMed
Introduction In the United States and several other countries, the incidence of papillary thyroid cancer (PTC) has significantly increased in recent decades ( 1 ). PTC is now the second most commonly diagnosed malignancy among US Latinas ( 2
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Marco Marino in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Valentina Cirello in
Google Scholar
PubMed
Search for other papers by Valentina Gnarini in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Elisa Pignatti in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Livio Casarini in
Google Scholar
PubMed
Search for other papers by Chiara Diazzi in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Vincenzo Rochira in
Google Scholar
PubMed
Search for other papers by Katia Cioni in
Google Scholar
PubMed
Search for other papers by Bruno Madeo in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Cesare Carani in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Manuela Simoni in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Introduction Thyroid cancers can be well-differentiated, as papillary and follicular subtypes, or poorly differentiated and anaplastic carcinomas. Papillary thyroid carcinoma (PTC) represents up to 80% of all the thyroid cancer cases. Various
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Wensi Huang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Yuying Deng in
Google Scholar
PubMed
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
Introduction Over the last decades, thyroid cancer has been the fastest growing and most prevalent endocrine malignancy worldwide. The Cancer Center of China has recently reported that thyroid cancer was the eighth most common cancer and